Home
Conditions
Cell Transformation, Neoplastic

Clinical trial condition

Cell Transformation, Neoplastic

Explore clinical trials studying Cell Transformation, Neoplastic. Study availability and eligibility vary by location and protocol.

270 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Cell Transformation, Neoplastic trial results

Completed

CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase

NCT00084916

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +44 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome

NCT00005064

Conditions: Adult Acute Promyelocytic Leukemia (M3), Anemia, Anemia, Refractory, +34 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

NCT00087204

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +45 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia

NCT00006213

Conditions: Adult Acute Promyelocytic Leukemia (M3), Anemia, Anemia, Refractory, +37 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

NCT00005805

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

NCT00008359

Conditions: Adnexal Diseases, Agranulocytosis, Amyloidosis, +141 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia

NCT00053963

Conditions: Astrocytoma, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +75 more
Locations: Children's Oncology Group Arcadia, California, United States

View Trial Details

Completed

SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes

NCT00098826

Conditions: Acute Undifferentiated Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +60 more
Locations: Case Western Reserve University Cleveland, Ohio, United States

View Trial Details

Completed

Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer

NCT00012376

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +46 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia

NCT00345826

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +22 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Cell Transformation, Neoplastic

Cell Transformation, Neoplastic trial results

Related conditions